| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | EVP of Research | Common Stock | 69,379 | $781,208 | $11.26 | 02 Mar 2022 | Direct |
| Aurinia Pharmaceuticals Inc. | EVP of Research | Stock Option (right to buy) | 106,838 | 02 Mar 2022 | Direct | ||
| Aurinia Pharmaceuticals Inc. | EVP of Research | Restricted Stock Unit | 62,448 | 02 Mar 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | 02 Mar 2022 | 4 | -$58,236 | 4 | EVP of Research | 04 Mar 2022, 15:10 |
| AUPH | Aurinia Pharmaceuticals Inc. | 25 Oct 2021 | 3 | -$3,563,500 | 4 | EVP of Research | 26 Oct 2021, 16:33 |
| AUPH | Aurinia Pharmaceuticals Inc. | 21 Sep 2021 | 6 | -$701,818 | 4 | EVP of Research | 22 Sep 2021, 16:53 |
| AUPH | Aurinia Pharmaceuticals Inc. | 10 Sep 2021 | 3 | -$687,325 | 4 | EVP of Research | 14 Sep 2021, 17:12 |
| AUPH | Aurinia Pharmaceuticals Inc. | 07 Sep 2021 | 1 | -$91,500 | 4 | EVP of Research | 08 Sep 2021, 16:03 |
| AUPH | Aurinia Pharmaceuticals Inc. | 11 May 2021 | 2 | +$120,800 | 4 | Ex Vice President of Research | 11 May 2021, 17:22 |